Jefferies Group LLC Bei Gene, Ltd. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 15, 2020
SELL
$121.84 - $173.19 $2.05 Million - $2.91 Million
-16,800 Reduced 55.08%
13,700 $1.69 Million
Q4 2019

Feb 13, 2020
SELL
$115.78 - $208.34 $324,184 - $583,352
-2,800 Reduced 8.41%
30,500 $5.06 Million
Q3 2019

Nov 13, 2019
BUY
$120.61 - $148.29 $4.02 Million - $4.94 Million
33,300 New
33,300 $4.08 Million

Others Institutions Holding BGNE

# of Institutions
253
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $22.7B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email